Nomura Securities upgraded shares of Hoya (OTCMKTS:HOCPY - Free Report) to a strong-buy rating in a research note issued to investors on Monday morning,Zacks.com reports.
A number of other equities analysts have also recently issued reports on the stock. Erste Group Bank upgraded shares of Hoya from a "hold" rating to a "strong-buy" rating in a research report on Friday, May 23rd. The Goldman Sachs Group raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Three analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, Hoya currently has a consensus rating of "Strong Buy".
Check Out Our Latest Stock Analysis on HOCPY
Hoya Price Performance
OTCMKTS:HOCPY traded up $0.18 during trading hours on Monday, hitting $130.89. The stock had a trading volume of 13,099 shares, compared to its average volume of 28,315. The company has a 50 day simple moving average of $123.71 and a two-hundred day simple moving average of $119.71. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.19 and a quick ratio of 4.21. Hoya has a one year low of $97.4930 and a one year high of $148.27. The firm has a market capitalization of $44.91 billion, a price-to-earnings ratio of 32.72, a P/E/G ratio of 2.61 and a beta of 0.91.
Hoya (OTCMKTS:HOCPY - Get Free Report) last announced its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 EPS for the quarter, beating the consensus estimate of $1.04 by $0.01. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.47 billion. Hoya had a net margin of 23.57% and a return on equity of 21.01%. Research analysts forecast that Hoya will post 3.66 earnings per share for the current fiscal year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
See Also
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.